Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Five Prime Therapeutics (FPRX) News Today

Five Prime Therapeutics logo
CMMB Chemomab Therapeutics Ltd.
What Is The Prime Rate Today?
Oral Covid vaccine developer nails down Peninsula space
Get Five Prime Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FPRX and its competitors with MarketBeat's FREE daily newsletter.

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover

FPRX Media Mentions By Week

FPRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FPRX
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

FPRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FPRX Articles
This Week

0

0

FPRX Articles
Average Week

Get Five Prime Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for FPRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:FPRX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners